GPCR – structure therapeutics inc. - american depositary shares (US:NASDAQ)
Stock Stats
News
Structure Therapeutics (NASDAQ:GPCR) was given a new $50.00 price target on by analysts at Stifel Nicolaus.
Structure Therapeutics (NASDAQ:GPCR) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Structure Therapeutics (NASDAQ:GPCR) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
BMO Capital Remains Bullish on Structure Therapeutics (GPCR), Cites Upcoming Trial Readouts [Yahoo! Finance]
Structure Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
Form SCHEDULE 13G/A Structure Therapeutics Filed by: JANUS HENDERSON GROUP PLC
Form SCHEDULE 13G Structure Therapeutics Filed by: Avoro Capital Advisors LLC
Form SCHEDULE 13G/A Structure Therapeutics Filed by: Deep Track Capital, LP
Form SCHEDULE 13G/A Structure Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
Form SCHEDULE 13G/A Structure Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.